drugset / Trial / NCT02482298
A Study to Assess the Effect of Ticagrelor in Reducing the Number of Days With Pain in Patients With Sickle Cell Disease
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to determine whether ticagrelor is effective in reducing the number of days of pain, intensity of pain, and reducing the use of analgesics due to sickle cell disease
Timeline
- Start
- 2015-07-09
- Primary completion
- 2016-11-16
- Completion
- 2016-11-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ticagrelor | Small molecule | 10 mg | Oral |
| Subject | Ticagrelor | Small molecule | 45 mg | Oral |